<DOC>
	<DOCNO>NCT01802762</DOCNO>
	<brief_summary>To assess feasibility new neuromonitoring system ( NeMoSystem include NeMo Probe NeMo Patch ) accuracy measurement value ( cerebral blood flow ( CBF ) ; cerebral blood volume ( CBV ) ) obtain .</brief_summary>
	<brief_title>A New Multi-parameter Neuromonitoring System Save Patients ' Lives Stroke Brain Injury</brief_title>
	<detailed_description />
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<criteria>1 . Adult male female patient , ≥ 18 ≤ 75 year 2 . Patient severe SAH ( GCS ≤ 12 ) severe TBI ( GCS ≤ 8 ) 3 . Decreased level consciousness need ICP monitoring estimate duration 3 day 4 . Negative pretreatment serum pregnancy test female patient childbearing potential 5 . In patient severe SAH severe TBI need ICP monitor acute emergency situation exist . The inclusion follow 1 . Known kidney disease , define plasma creatinine &gt; 120 µmol/l 2 . Known liver disease , define GOT &gt; 200U/l 3 . History allergic disorder , include allergic reaction contrast agent contain iodine , ICG plaster , well patient thyroid disease cause hyperthyroidism 4 . Preexisting disability and/or legal representative 5 . Participation another interventional clinical trial within last 30 day start treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>